Skip to main content
Premium Trial:

Request an Annual Quote

Amersham, GeneticXchange Soon to Sell Co-Developed Data-Integration Tool

NEW YORK, July 10 - Amersham Biosciences and GeneticXchange have co-developed a platform to help researchers integrate lab-generated data with legacy, public, third party, and clinical data, the firms said today.

The platform brings together Amersham's Scierra Laboratory Workflow System with GeneticXchange's discoveryHub data-integration platform. It will be available during the current quarter, and Amersham will sell it worldwide.


Financial terms were not disclosed. 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.